This review aims to systematically analyze TLR-4-mediated chemoresistance mechanisms in ovarian cancer, breast cancer, liver cancer, cervical cancer, colorectal cancer and other malignancies induced by drugs like paclitaxel, cisplatin, docetaxel (DTX), 5-fluorouracil. Here, TLR4 is linked to ovarian carcinoma.